A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a Infection

Abstract
Four hundred fifty volunteers participated in a placebo-controlled, double-blind, randomized trial of the prophylactic effects of rimantadine and amantadine during an outbreak of influenza A. The subjects received drugs orally at a dose of 100 mg twice a day for six weeks.